The initiative ensures veterans of the Armed Services will have access to comprehensive pharmacogenomic and germline genetic ...

Two major Australian health insurers, Bupa and Medibank, have started offering genetic testing meant to tell you your likely reaction to certain medications. Subscribe to our newsletter for the latest ...

Pharmacogenomic testing, a mature and growing aspect of personalized medicine, has demonstrated significant ability to enhance health outcomes and reduce healthcare costs. Since the 1970s, ...

Pharmacogenomic testing for antidepressants could help reduce the time and cost it takes to find the most effective medication for a patient, according to a new study. Scientists developed a ...

Their aim is to reduce unnecessary drug use by identifying medicines suited to an individual’s genetic profile ...

Genetic testing presents major growth opportunities in predictive diagnostics, pharmacogenomic testing, and direct-to-consumer markets. With increasing test volumes and lower prices, the industry is ...

A special kind of genetic test that helps determine the best antidepressant for patients with moderate-to-severe depression could generate substantive health system savings and greatly improve patient ...

Pharmacogenomic (PGx) testing is a growing area of personalized medicine with demonstrated clinical utility in improving patient outcomes in oncology. PGx testing of pharmacogenes affecting drug ...

Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized ...